ADIPOQ and chronic kidney disease: In a case–control study (Sedighi and Abediankenari, 2014) enrolling 42 CKD patients and 42 healthy controls, adiponectin in CKD patients was significantly higher than that in the healthy controls and was inversely correlated with eGFR.